Cargando…
Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events
During pregnancy, the maternal host must adapt in order to enable growth of the fetus. These changes affect all organ systems and are designed both to protect the fetus and to minimize risk to the mother. One of the most prominent adaptations involves the immune system. The semi‐allogenic fetoplacen...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100418/ https://www.ncbi.nlm.nih.gov/pubmed/36377667 http://dx.doi.org/10.1111/imr.13169 |
_version_ | 1785025274243448832 |
---|---|
author | Smith‐Jackson, Kate Harrison, Richard Alexander |
author_facet | Smith‐Jackson, Kate Harrison, Richard Alexander |
author_sort | Smith‐Jackson, Kate |
collection | PubMed |
description | During pregnancy, the maternal host must adapt in order to enable growth of the fetus. These changes affect all organ systems and are designed both to protect the fetus and to minimize risk to the mother. One of the most prominent adaptations involves the immune system. The semi‐allogenic fetoplacental unit has non‐self components and must be protected against attack from the host. This requires both attenuation of adaptive immunity and protection from innate immune defense mechanisms. One of the key innate immune players is complement, and it is important that the fetoplacental unit is not identified as non‐self and subjected to complement attack. Adaptation of the complement response must, however, be managed in such a way that maternal protection against infection is not compromised. As the complement system also plays a significant facilitating role in many of the stages of a normal pregnancy, it is also important that any necessary adaptation to accommodate the semi‐allogenic aspects of the fetoplacental unit does not compromise this. In this review, both the physiological role of the alternative pathway of complement in facilitating a normal pregnancy, and its detrimental participation in pregnancy‐specific disorders, are discussed. |
format | Online Article Text |
id | pubmed-10100418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101004182023-04-14 Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events Smith‐Jackson, Kate Harrison, Richard Alexander Immunol Rev Invited Reviews During pregnancy, the maternal host must adapt in order to enable growth of the fetus. These changes affect all organ systems and are designed both to protect the fetus and to minimize risk to the mother. One of the most prominent adaptations involves the immune system. The semi‐allogenic fetoplacental unit has non‐self components and must be protected against attack from the host. This requires both attenuation of adaptive immunity and protection from innate immune defense mechanisms. One of the key innate immune players is complement, and it is important that the fetoplacental unit is not identified as non‐self and subjected to complement attack. Adaptation of the complement response must, however, be managed in such a way that maternal protection against infection is not compromised. As the complement system also plays a significant facilitating role in many of the stages of a normal pregnancy, it is also important that any necessary adaptation to accommodate the semi‐allogenic aspects of the fetoplacental unit does not compromise this. In this review, both the physiological role of the alternative pathway of complement in facilitating a normal pregnancy, and its detrimental participation in pregnancy‐specific disorders, are discussed. John Wiley and Sons Inc. 2022-11-15 2023-01 /pmc/articles/PMC10100418/ /pubmed/36377667 http://dx.doi.org/10.1111/imr.13169 Text en © 2022 The Authors. Immunological Reviews published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Invited Reviews Smith‐Jackson, Kate Harrison, Richard Alexander Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title | Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title_full | Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title_fullStr | Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title_full_unstemmed | Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title_short | Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
title_sort | alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events |
topic | Invited Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100418/ https://www.ncbi.nlm.nih.gov/pubmed/36377667 http://dx.doi.org/10.1111/imr.13169 |
work_keys_str_mv | AT smithjacksonkate alternativepathwayactivationinpregnancyameasuredamountcomplementsasuccessfulpregnancytoomuchresultsinadverseevents AT harrisonrichardalexander alternativepathwayactivationinpregnancyameasuredamountcomplementsasuccessfulpregnancytoomuchresultsinadverseevents |